Cargando…

RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer

Preoperative chemotherapy, often using docetaxel and cisplatin, is a famous treatment option for advanced gastric cancer in Japan. But, there are no effective biomarkers that predict the therapeutic outcome on gastric cancer. Ribophorin II (RPN2) silencing, which decreases glycosylation of P-glycopr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimoto, Daisuke, Goi, Takanori, Koneri, Kenji, Hirono, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880597/ https://www.ncbi.nlm.nih.gov/pubmed/29632637 http://dx.doi.org/10.18632/oncotarget.24622

Ejemplares similares

Five-Year Survival of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report
por: Koneri, Kenji, et al.
Publicado: (2013)

Large-cell neuroendocrine carcinoma of the common bile duct: a case report and a review of literature
por: Murakami, Makoto, et al.
Publicado: (2016)

Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015)

Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
por: Oh, S C, et al.
Publicado: (2005)

The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion
por: Fujimoto, Daisuke, et al.
Publicado: (2010)

Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report)
por: Sawai, Katsuji, et al.
Publicado: (2013)

A typical case of resected pancreatic hamartoma: a case report and literature review on imaging and pathology
por: Katayama, Hokahiro, et al.
Publicado: (2020)

Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015)

PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway
por: Fujimoto, Daisuke, et al.
Publicado: (2015)

A report of amelanotic malignant melanoma of the esophagus diagnosed appropriately with novel markers: A case report
por: Kobayashi, Junya, et al.
Publicado: (2018)

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma
por: Kurashige, J, et al.
Publicado: (2012)

Complete Remission of Advanced Gastric Cancer in Response to Chemotherapy With Docetaxel, Cisplatin and Capecitabine (dcx)
por: Marroqui, Asuncion Juarez, et al.
Publicado: (2011)

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004)

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
por: Hilkens, P. H., et al.
Publicado: (1997)

Stage IV anal canal squamous cell carcinoma with long-term survival: a case report
por: Sawai, Katsuji, et al.
Publicado: (2022)

Phase II Trial of Preoperative Chemotherapy with Docetaxel, Cisplatin and S-1 for T4 Locally Advanced Gastric Cancer
por: Fushida, Sachio, et al.
Publicado: (2012)

Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
por: Takayama, T, et al.
Publicado: (2007)

Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer
por: TAS, FARUK, et al.
Publicado: (2013)

Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma
por: Guo, Ming gao, et al.
Publicado: (2014)

Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma()()()()
por: Jin, Ting, et al.
Publicado: (2019)

Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer
por: Dassen, Anneriet E, et al.
Publicado: (2016)

Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets
por: Lu, Xiuxiu, et al.
Publicado: (2017)

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer
por: Hayashi, Tsutomu, et al.
Publicado: (2020)

Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
por: Yu, Deguo, et al.
Publicado: (2022)

MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer
por: FUJISHIMA, YUKA, et al.
Publicado: (2012)

Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer
por: Yoshida, Yu, et al.
Publicado: (2018)

Follicular cholangitis mimicking a common bile duct cancer: a case report
por: Koneri, Kenji, et al.
Publicado: (2023)

A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
por: Park, Y H, et al.
Publicado: (2004)

Fructan Improves Survival and Function of Cryopreserved Rat Islets
por: Nishino, Takuma, et al.
Publicado: (2021)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
por: Zeng, Zhen, et al.
Publicado: (2018)

Structure of Rpn10 and Its Interactions with Polyubiquitin Chains and the Proteasome Subunit Rpn12
por: Riedinger, Christiane, et al.
Publicado: (2010)

Redundant Roles of Rpn10 and Rpn13 in Recognition of Ubiquitinated Proteins and Cellular Homeostasis
por: Hamazaki, Jun, et al.
Publicado: (2015)

Relationship between the Expression of the Thymidylate Synthase and the Prognosis of Gastric Cancer Patients Treated with Combinational Chemotherapy Regimen Including Fluorouracil, Docetaxel and Cisplatin
por: Aznab, Mozaffar, et al.
Publicado: (2020)

The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015)

The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1(No correlation coefficient between VEGF and PROK1)
por: Goi, Takanori, et al.
Publicado: (2015)

Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery
por: Liu, Yan, et al.
Publicado: (2016)

Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer
por: Kubota, Hiroki, et al.
Publicado: (2017)

Structural and functional characterization of Rpn12 identifies residues required for Rpn10 proteasome incorporation
por: Boehringer, Jonas, et al.
Publicado: (2012)

Adjuvant Chemotherapy with Docetaxel, Cisplatin, and Continuous-Infusion 5-Fluorouracil for Gastric Cancer: A Phase II Study()
por: Meng, Changting, et al.
Publicado: (2014)

Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
por: Lim, Do Hyoung, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_o57q158hd3ivgopjkk0ja6c3qi